Apolipoprotein A-I and B levels in adolescents; a trial to define subjects at risk for coronary heart disease

Acta paediatrica Scandinavica
T Sveger, G Fex

Abstract

The normal levels of apolipoprotein A-I and B (apo A-I, apo B) were determined in 220 male and 340 female 16-19-year-old adolescents. In addition to these apolipoproteins, total and high density lipoprotein cholesterol (total-C HDL-C) were analysed in an attempt to define subjects at high risk for coronary heart disease (CHD). The normal levels were for boys: apo A-I 0.96 +/- 0.13 g/l, apo B 0.64 +/- 0.14 g/l; for girls: apo A-I 1.04 +/- 0.18 g/l, apo B 0.65 +/- 0.14 g/l; for girls taking combined oral contraceptives: apo A-I 1.14 +/- 0.22 g/l, apo B 0.72 +/- 0.16 g/l. Subjects with the following high-risk profiles were selected for further follow-up: 1. Total-C and apo B greater than or equal to 95th percentile; 2. Total-C or apo B greater than or equal to 95th and HDL-C or apo A-I less than or equal to 5th percentile. Seven adolescents had the combination of high total-C and apo B. None had any of the other combinations. One girl had lipid, apolipoprotein levels and a family history indicating familial hypercholesterolemia (f.h.). Another two adolescents were suspected of having f.h. while one girl might have abnormal levels secondary to oral combined contraceptives. The study suggests that the analyses of apolipoproteins, es...Continue Reading

References

Jul 1, 1976·The American Journal of Cardiology·W B KannelT Gordon
Feb 1, 1975·Circulation·D S Fredrickson
Jun 1, 1976·Metabolism: Clinical and Experimental·J J AlbersJ J Hoover
Aug 16, 1976·Clinica Chimica Acta; International Journal of Clinical Chemistry·P N DurringtonM Hartog
Feb 1, 1978·European Journal of Clinical Investigation·J B KarlinA H Rubenstein
Jul 6, 1978·The New England Journal of Medicine·D D BradleyS Ramcharan
Jan 1, 1978·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·B DanielssonB G Petersson
Jul 16, 1979·Clinica Chimica Acta; International Journal of Clinical Chemistry·P AvogaroG B Quinci
Jan 1, 1972·Scandinavian Journal of Clinical and Laboratory Investigation. Supplementum·C B Laurell
May 1, 1974·The Journal of Clinical Investigation·G SchonfeldB Pfleger
Jan 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·A SnidermanP O Kwiterovich
Jan 15, 1980·Clinica Chimica Acta; International Journal of Clinical Chemistry·A VérineJ Boyer

❮ Previous
Next ❯

Citations

Feb 1, 1990·Journal of Clinical Chemistry and Clinical Biochemistry. Zeitschrift Für Klinische Chemie Und Klinische Biochemie·F BuserR Mordasini
May 10, 2013·Critical Reviews in Clinical Laboratory Sciences·Julie L V ShawKhosrow Adeli
Jan 26, 2016·Metabolic Syndrome and Related Disorders·Harry Robberecht, Nina Hermans
Jan 1, 1985·Acta Paediatrica Scandinavica. Supplement·T Solakivi-JaakkolaM Pietikäinen
Mar 1, 1987·Acta paediatrica Scandinavica·T SvegerN Borgfors
Jan 27, 1995·The Journal of Biological Chemistry·T M Misenheimer, D F Mosher

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.